255 related articles for article (PubMed ID: 31876914)
1. Comparative Effectiveness of Proton vs Photon Therapy as Part of Concurrent Chemoradiotherapy for Locally Advanced Cancer.
Baumann BC; Mitra N; Harton JG; Xiao Y; Wojcieszynski AP; Gabriel PE; Zhong H; Geng H; Doucette A; Wei J; O'Dwyer PJ; Bekelman JE; Metz JM
JAMA Oncol; 2020 Feb; 6(2):237-246. PubMed ID: 31876914
[TBL] [Abstract][Full Text] [Related]
2. Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era.
Iocolano M; Yegya-Raman N; Friedes C; Wang X; Kegelman T; Lee SH; Duan L; Li B; Levin WP; Cengel KA; Konski A; Langer CJ; Cohen RB; Sun L; Aggarwal C; Doucette A; Xiao Y; Kevin Teo BK; O'Reilly S; Zou W; Bradley JD; Simone CB; Feigenberg SJ
Cancer; 2024 Jun; 130(11):2031-2041. PubMed ID: 38294959
[TBL] [Abstract][Full Text] [Related]
3. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
Chang JY; Verma V; Li M; Zhang W; Komaki R; Lu C; Allen PK; Liao Z; Welsh J; Lin SH; Gomez D; Jeter M; O'Reilly M; Zhu RX; Zhang X; Li H; Mohan R; Heymach JV; Vaporciyan AA; Hahn S; Cox JD
JAMA Oncol; 2017 Aug; 3(8):e172032. PubMed ID: 28727865
[TBL] [Abstract][Full Text] [Related]
4. Sequential proton boost after standard chemoradiation for high-grade glioma.
Adeberg S; Bernhardt D; Harrabi SB; Uhl M; Paul A; Bougatf N; Verma V; Unterberg A; Wick W; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
Radiother Oncol; 2017 Nov; 125(2):266-272. PubMed ID: 29050959
[TBL] [Abstract][Full Text] [Related]
5. Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only. Evaluation of toxicity and efficacy.
Alterio D; D'Ippolito E; Vischioni B; Fossati P; Gandini S; Bonora M; Ronchi S; Vitolo V; Mastella E; Magro G; Franco P; Ricardi U; Krengli M; Ivaldi G; Ferrari A; Fanetti G; Comi S; Tagliabue M; Verri E; Ricotti R; Ciardo D; Jereczek-Fossa BA; Valvo F; Orecchia R
Acta Oncol; 2020 May; 59(5):541-548. PubMed ID: 32090645
[No Abstract] [Full Text] [Related]
6. Proton versus photon radiotherapy for primary hepatocellular carcinoma: a propensity-matched analysis.
Cheng JY; Liu CM; Wang YM; Hsu HC; Huang EY; Huang TT; Lee CH; Hung SP; Huang BS
Radiat Oncol; 2020 Jun; 15(1):159. PubMed ID: 32605627
[TBL] [Abstract][Full Text] [Related]
7. Acute toxicity in patients treated with concurrent chemoradiotherapy with proton versus intensity-modulated radiation therapy for nonmetastatic head and neck cancers.
Kim KN; Harton J; Mitra N; Lukens JN; Lin A; Amaniera I; Doucette A; Gabriel P; Baumann B; Metz J; Wojcieszynski A
Head Neck; 2022 Nov; 44(11):2386-2394. PubMed ID: 35822438
[TBL] [Abstract][Full Text] [Related]
8. Initial Report of a Prospective Dosimetric and Clinical Feasibility Trial Demonstrates the Potential of Protons to Increase the Therapeutic Ratio in Breast Cancer Compared With Photons.
Bradley JA; Dagan R; Ho MW; Rutenberg M; Morris CG; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):411-421. PubMed ID: 26611875
[TBL] [Abstract][Full Text] [Related]
9. Quantification of global lung inflammation using volumetric 18F-FDG PET/CT parameters in locally advanced non-small-cell lung cancer patients treated with concurrent chemoradiotherapy: a comparison of photon and proton radiation therapy.
Rice SR; Saboury B; Houshmand S; Salavati A; Kalbasi A; Goodman CR; Werner TJ; Vujaskovic Z; Simone CB; Alavi A
Nucl Med Commun; 2019 Jun; 40(6):618-625. PubMed ID: 31095527
[TBL] [Abstract][Full Text] [Related]
10. Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival.
Sanford NN; Pursley J; Noe B; Yeap BY; Goyal L; Clark JW; Allen JN; Blaszkowsky LS; Ryan DP; Ferrone CR; Tanabe KK; Qadan M; Crane CH; Koay EJ; Eyler C; DeLaney TF; Zhu AX; Wo JY; Grassberger C; Hong TS
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):64-72. PubMed ID: 30684667
[TBL] [Abstract][Full Text] [Related]
11. Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study.
Mohamad O; Tabuchi T; Nitta Y; Nomoto A; Sato A; Kasuya G; Makishima H; Choy H; Yamada S; Morishima T; Tsuji H; Miyashiro I; Kamada T
Lancet Oncol; 2019 May; 20(5):674-685. PubMed ID: 30885458
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer.
Colaco RJ; Huh S; Nichols RC; Morris CG; D'Agostino H; Flampouri S; Li Z; Pham DC; Bajwa AA; Hoppe BS
Acta Oncol; 2013 Apr; 52(3):506-13. PubMed ID: 23438357
[TBL] [Abstract][Full Text] [Related]
13. Early outcomes of breast cancer patients treated with post-mastectomy uniform scanning proton therapy.
Luo L; Cuaron J; Braunstein L; Gillespie E; Kahn A; McCormick B; Mah D; Chon B; Tsai H; Powell S; Cahlon O
Radiother Oncol; 2019 Mar; 132():250-256. PubMed ID: 30414757
[TBL] [Abstract][Full Text] [Related]
14. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
15. Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy.
Kim N; Myoung Noh J; Lee W; Park B; Park H; Young Park J; Pyo H
Radiother Oncol; 2021 Mar; 156():166-173. PubMed ID: 33359267
[TBL] [Abstract][Full Text] [Related]
16. Photon vs. proton radiochemotherapy: Effects on brain tissue volume and perfusion.
Petr J; Platzek I; Hofheinz F; Mutsaerts HJMM; Asllani I; van Osch MJP; Seidlitz A; Krukowski P; Gommlich A; Beuthien-Baumann B; Jentsch C; Maus J; Troost EGC; Baumann M; Krause M; van den Hoff J
Radiother Oncol; 2018 Jul; 128(1):121-127. PubMed ID: 29370984
[TBL] [Abstract][Full Text] [Related]
17. Differences in Normal Tissue Response in the Esophagus Between Proton and Photon Radiation Therapy for Non-Small Cell Lung Cancer Using In Vivo Imaging Biomarkers.
Niedzielski JS; Yang J; Mohan R; Titt U; Mirkovic D; Stingo F; Liao Z; Gomez DR; Martel MK; Briere TM; Court LE
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):1013-1020. PubMed ID: 29063837
[TBL] [Abstract][Full Text] [Related]
18. Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer.
Hiroshima Y; Fukumitsu N; Saito T; Numajiri H; Murofushi KN; Ohnishi K; Nonaka T; Ishikawa H; Okumura T; Sakurai H
Radiother Oncol; 2019 Jul; 136():37-43. PubMed ID: 31015127
[TBL] [Abstract][Full Text] [Related]
19. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
20. Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study.
Wo JY; Plastaras JP; Metz JM; Jiang W; Yeap BY; Drapek LC; Adams J; Baglini C; Ryan DP; Murphy JE; Parikh AR; Allen JN; Clark JW; Blaszkowsky LS; DeLaney TF; Ben-Josef E; Hong TS
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):90-95. PubMed ID: 31128146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
